Prothena to Participate in the Barclays Global Healthcare Conference
Mar 07, 2018 21:05 pm UTC| Business
DUBLIN, Ireland, March 07, 2018 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the neuroscience...
Aduro Biotech to Present at the 38th Annual Cowen Healthcare Conference
Mar 07, 2018 21:02 pm UTC| Business
BERKELEY, Calif., March 07, 2018 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Andrea van Elsas, chief scientific officer of Aduro, will present at the 38th Annual Cowen Healthcare Conference in Boston, MA...
Mar 07, 2018 21:02 pm UTC| Business
PRINCETON JUNCTION, N.J., March 07, 2018 -- MISTRAS Group, Inc. (NYSE:MG) will have a conference call on Tuesday, March 13, 2018 at 9:00 a.m. Eastern Time to discuss its results for the fourth quarter and fiscal year...
Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
Mar 07, 2018 21:02 pm UTC| Business
Two novel anti-epileptic drugs advancing in clinical development; Interim XEN1101 Phase 1 data expected to be released in May 2018 at scientific symposium; Xenon announces new clinical stage ion channel product to...
Esperion to Participate in Fireside Chat at March 2018 Investor Conferences
Mar 07, 2018 21:02 pm UTC| Business
ANN ARBOR, Mich., March 07, 2018 -- Esperion (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing complementary, convenient, cost-effective, once-daily, oral therapies for the treatment...
Celldex Provides Corporate Update and Reports Full Year 2017 Results
Mar 07, 2018 21:02 pm UTC| Business
HAMPTON, N.J., March 07, 2018 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the fourth quarter and year ended December 31, 2017. The Company will host a conference call...
Marten Transport Declares Quarterly Dividend
Mar 07, 2018 21:02 pm UTC| Business
MONDOVI, Wis., March 07, 2018 -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of two and one half cents ($0.025) per share of common...